Ali Mortazavi, the long-serving chief executive of Silence Therapeutics PLC ( LON:SLN), is stepping down from his role with immediate effect. Mortazavi, who had been at the helm of the RNA therapeutics specialist for six years, will be replaced temporarily by the company’s chair, Annalisa Jenkins, until a permanent successor is found.
Name: Ali Mortazavi
Continent: North America
Company: Silence Therapeutics
Announcement Date: June 03, 2018, 10:00pm
Resignation Date: June 03, 2018, 10:00pm